Keytruda is an immunotherapy drug that is prescribed to cancer patients and is used to treat different types of cancer. It was first approved by the FDA in 2014 for the treatment of advanced or ...

Overview: Keytruda Qlex is a medicine that is used to treat many types of cancer. This medicine is given to you as an injection under your skin by a health care provider. This medicine can cause side ...

Merck has bagged another early cancer nod for Keytruda, and this one could be worth more than $1 billion in peak sales. The FDA has approved Keytruda for treating patients with early renal cell ...

With at least seven Indian manufacturers in the race to develop generic versions of Merck & Co’s best-selling cancer immunotherapy drug Keytruda, doctors and researchers say a far cheaper alternative ...

Merck & Co.’s Keytruda has risen from the ashes with a positive stomach cancer trial readout. But there’s some reconciliation to do with a past failure that led to the withdrawal of an accelerated ...

An expert explains the recent movement towards the use of immunotherapy for patients with resectable NSCLC. The recent approval by the Food and Drug Administration (FDA) of Keytruda (pembrolizumab) ...

KEYTRUDA QLEX is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute RAHWAY, N.J.--(BUSINESS WIRE)-- Merck ...

What is one lesson you learned from your time at Merck, specifically in developing Keytruda, that you’re bringing to the Eikon team? Drug development is a team sport. You have to build a great team.

Counterfeit Keytruda drugs raise patient safety and drug verification concerns globally Keytruda is effective for advanced cancers but costs up to Rs 1.5 lakh monthly in India High prices drive ...